(A) Schematic for studying time course of corticalisation in female Dmp1Cre:Socs3f/f mice. (B) Femur length at 6, and 12 to 16 weeks of age in female Dmp1Cre:Socs3f/f and control mice; *p<0.05 for …
Raw data for cortical porosity measurements.
Data are mean ± SEM; n = 11 mice per group; p value derived by Welch’s t-test.
(A) Diagram showing region measured, and Otsu thresholding of a raw micro-CT image. (B) Bone volume, as a percentage of total metaphyseal volume, segregated by low, mid and high density volumes, at …
Raw data for bone density measurements at all three densities.
(A) The metaphyseal region was analysed in consecutive 9 micron slices. (B–E) Bone volume at low-, mid-, and high-density mineral levels in each slice from the distal to proximal end of the …
Bone volume at low-, mid-, and high-density mineral levels in each slice from the distal to proximal end of the metaphyseal region at 12 weeks and 15 weeks in Dmp1Cre and Dmp1Cre:Socs3f/f mice.
Data are mean ± SEM; n = 9–11 mice per group.
Data are mean with SEM shown by dashed lines, taken slice by slice through the metaphysis (see Figure 3A for schematic). Gray region indicates significant difference between genotypes by repeated …
(A) Bone volume, as a percentage of total metaphyseal volume, segregated by low, mid and high density volumes; changes in low-, mid- and high-density bone are indicated by coloured asterisks; error …
(A-C) Mice were given a single calvarial injection of murine oncostatin M (mOSM) (A), murine leukaemia inhibitory factor (mLIF) (B), or human interleukin- 11 (hIL-11) (C). Calvariae were collected …
Uncropped gels for phospho-STAT3 (left panels) and total STAT3/pan actin (right panels) for calvarial samples from Socs3f/f and Dmp1Cre:Socs3f/f mice treated with OSM (A), LIF (B) or IL-11 (C).
Details of molecular weight markers and legends for the gels are in Figure 4.
Metaphyseal cortical porosity in female and male control (Dmp1Cre) and Dmp1Cre:Il6stf/f mice (A) and Dmp1Cre:Socs3f/f and Dmp1Cre:Socs3f/f:Il6stf/f mice (B) and representative Otsu-based …
Bone volume at low-, mid-, and high-density mineral levels in each slices from the distal to proximal end of the metaphyseal region in 12 week old female and male Dmp1Cre:Socs3f/f mice and Dmp1Cre:Socs3f/f:Il6stf/f mice.
Data are mean with SEM shown by dashed lines, taken slice by slice through the metaphysis (see Figure 3A for schematic). Data are mean ± SEM; n = 9–11 mice per group. Gray region indicates …
(A,B) Representative calcein labelling in Dmp1Cre:Socs3f/f and Dmp1Cre:Socs3f/f:Il6stf/f mice. Pink dashed lines show transcortical pores. (C–E) Histomorphometry of cortical void area (Vd.Ar/Ct.Ar), …
(A) Ploton silver stain in the tibial lateral metaphysis of a 12 week old Dmp1Cre mouse; for comparison with Figure 6M,N. (B) Area of voids (diplöe) as a proportion of calvarial bone from 12 week …
Pseudocolourisation reflects the same density scale shown in Figure 1.
Pseudocolourisation reflects the same density scale shown in Figure 1.
Data are mean ± SEM. *, p<0.05, **, p<0.01; ***, p<0.001 vs sex- and age-matched controls (Dmp1Cre) by two-way ANOVA with Šidák post-hoc test.
Parameter | male | female | ||
---|---|---|---|---|
Dmp1Cre | Dmp1Cre:Il6stf/f | Dmp1Cre | Dmp1Cre:Il6stf/f | |
Number of samples | 7 | 10 | 6 | 6 |
IL6st:B2m (mRNA) | 1.14 ± 0.21 | 0.52 ± 0.08** | 0.88 ± 0.15 | 0.40 ± 0.18 |
Trabecular bone volume (%) Trabecular number (/mm) Trabecular Thickness (μm) Trabecular Separation (μm) | 13.72 ± 1.26 2.54 ± 0.21 53.5 ± 0.8 217 ± 14.01 | 8.24 ± 0.96** 1.27 ± 0.12*** 64.1 ± 2.6*** 469 ± 26*** | 10.82 ± 1.06 2.38 ± 0.22 45.6 ± 1.0 239 ± 15 | 6.06 ± 0.51** 1.12 ± 0.08*** 54.0 ± 1.3*** 415 ± 29*** |
Periosteal Perimeter (mm) Marrow Area (mm2) Moment of Inertia (mm4) | 7.21 ± 0.14 1.10 ± 0.04 0.395 ± 0.021 | 8.14 ± 0.25*** 1.37 ± 0.08*** 0.566 ± 0.51*** | 6.78 ± 0.13 0.94 ± 0.04 0.344 ± 0.02 | 7.29 ± 0.10* 1.11 ± 0.02* 0.404 ± 0.009 |
Bone Formation Rate/Bone Surface (%) Double labelled Surface/Bone Surface (%) Mineral Appositional Rate (μm/day) Osteoclast Surface/Bone Surface (%) | 0.454 ± 0.019 29.1 ± 1.8 1.30 ± 0.08 4.39 ± 0.58 | 0.295 ± 0.048** 20.1 ± 2.8** 1.10 ± 0.14 6.59 ± 0.89 | 0.704 ± 0.03 26.6 ± 1.5 1.98 ± 0.24 3.61 ± 0.45 | 0.481 ± 0.065* 15.1 ± 1.8** 1.63 ± 0.19 4.82 ± 0.83 |
Data are mean ± SEM normalised to the geometric mean of B2m and Hprt1; p values from two-way ANOVA analysis are shown in the right column, including p values for the comparison of male vs female, Dmp…
Parameter | male | female | p values | ||
---|---|---|---|---|---|
Dmp1Cre:Socs3f/f | Dmp1Cre:Socs3f/f:Il6stf/f | Dmp1Cre:Socs3f/f | Dmp1Cre:Socs3f/f:Il6stf/f | ||
Number of samples | 10 | 8 | 10 | 8 | |
Tnfsf11 (RANKL) Tnfrsf11b (OPG) Acp5 (TRAP) | 0.015 ± 0.002 0.067 ± 0.014 3.64 ± 0.36 | 0.016 ± 0.004 0.097 ± 0.017 1.94 ± 0.26 | 0.015 ± 0.003 0.026 ± 0.004 10.25 ± 1.45 | 0.015 ± 0.003 0.044 ± 0.009 7.41 ± 1.12 | Male vs female: 0.752; Genotype: 0.841; Interaction: 0.923. Male vs female: 0.0003; Genotype: 0.048; Interaction: 0.635. Male vs female:<0.0001; Genotype: 0.028; Interaction: 0.568. |
Data is mean ± SEM. *, p<0.05; **, p<0.01 vs Dmp1Cre:Socs3f/f by two-way ANOVA with Šidák post-hoc test.
Parameter | male | female | ||
---|---|---|---|---|
Dmp1Cre:Socs3f/f | Dmp1Cre:Socs3f/f:Il6stf/f | Dmp1Cre:Socs3f/f | Dmp1Cre:Socs3f/f:Il6stf/f | |
Number of samples | 9 | 11 | 10 | 9 |
Ultimate Force (N) Ultimate Deformation (mm) Yield Force (N) Yield Deformation (mm) Post-Yield Deformation (mm) Energy to Failure (mJ) Ultimate Stress (MPa) Ultimate Strain (%) Yield Stress (MPa) Yield Strain (%) Post-Yield Strain (%) | 16.48 ± 0.69 0.304 ± 0.025 15.44 ± 1.75 0.240 ± 0.022 0.063 ± 0.018 2.61 ± 0.31 47.30 ± 4.69 0.033 ± 0.003 41.65 ± 5.20 0.026 ± 0.003 0.007 ± 0.002 | 15.31 ± 0.60 0.330 ± 0.02 11.29 ± 0.70** 0.212 ± 0.022 0.126 ± 0.019* 2.94 ± 0.25 39.67 ± 1.72 0.036 ± 0.003 28.97 ± 1.46* 0.023 ± 0.003 0.014 ± 0.002* | 13.40 ± 0.25 0.350 ± 0.029 11.03 ± 0.58 0.282 ± 0.024 0.068 ± 0.013 2.34 ± 0.16 63.96 ± 2.39 0.034 ± 0.003 52.46 ± 3.02 0.028 ± 0.002 0.007 ± 0.001 | 13.79 ± 0.59 0.350 ± 0.019 10.19 ± 0.69 0.219 ± 0.026 0.152 ± 0.020** 2.99 ± 0.19* 54.29 ± 2.33 0.037 ± 0.002 40.42 ± 3.44 0.023 ± 0.003 0.016 ± 0.002** |
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | Dmp1Cre | Lynda Bonewald (Indiana University, USA) | Tg(Dmp1-cre)1Jqfe | C57BL/6 background |
Strain, strain background (Mus musculus) | Socs3tm1Wsa | Warren Alexander (Walter and Eliza Hal Institute) | Socs3tm1Wsa | C57BL/6 background |
Strain, strain background (Mus musculus) | Il6st-flox mouse strain | NCRR-NIH-supported KOMP Repository | IL6sttm1a(KOMP)Mbp | C57BL/6 background |
Antibody | phospho-STAT3 (Rabbit polyclonal) | Cell Signalling | Cat #9131 RRID:AB_331586 | IHC (1:100), WB (1:400) |
Antibody | STAT3 (mouse monoclonal) | Cell Signalling | Cat#9139 RRID:AB_331757 | WB (1:400) |
Antibody | Goat anti-Mouse | Dako | Cat#P0447 RRID:AB_2617137 | WB (1:1500) |
Antibody | Swine anti-Rabbit | Dako | Cat#P0217 RRID:AB_2728719 | IHC (1:250) WB (1:2000) |
Peptide, recombinant protein | Murine oncostatin M | R and D Systems | Cat#495-MO-025 | |
Peptide, recombinant protein | human IL-11 | R and D Systems | Cat#218-IL-025 | |
Peptide, recombinant protein | murine LIF | Merck Millipore | #LIF2010 | |
Peptide, recombinant protein | Murine Leptin | R and D Systems | #498-OB-01M | |
Peptide, recombinant protein | murine G-CSF | R and D Systems | #414-CS-005 |